These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24294772)

  • 1. [Tacrolimus in perianal manifestations of Crohn's disease].
    Nanaeva BA; Vardanian AV
    Eksp Klin Gastroenterol; 2013; (3):53-7. PubMed ID: 24294772
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastroduodenal, ileocolic and perianal Crohn's disease].
    Martins T; Correia F; Gonçalves P; Proença R; de Sousa S; Dias R
    Acta Med Port; 1996; 9(7-9):279-82. PubMed ID: 9005711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-α therapy.
    Nakase H; Matsuura M; Uza N; Chiba T
    Aliment Pharmacol Ther; 2011 Apr; 33(8):979-80; author reply 980-1. PubMed ID: 21434949
    [No Abstract]   [Full Text] [Related]  

  • 5. Review article: The medical treatment of Crohn's perianal fistulas.
    Schwartz DA; Herdman CR
    Aliment Pharmacol Ther; 2004 May; 19(9):953-67. PubMed ID: 15113362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory enterovesical and duodenocolic fistulas in Crohn's disease successfully managed with tacrolimus.
    Fukuda A; Nakase H; Seno H; Nabeshima M; Sawada M; Chiba T
    J Gastroenterol; 2005 Apr; 40(4):433-5. PubMed ID: 15870981
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus for Crohn's disease.
    Ruddock B
    Issues Emerg Health Technol; 2006 Sep; (88):1-4. PubMed ID: 16981314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: the role of tacrolimus in the management of Crohn's disease.
    McSharry K; Dalzell AM; Leiper K; El-Matary W
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1282-94. PubMed ID: 21999607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term tacrolimus: a promising therapeutic approach for Crohn's disease.
    Ierardi E; Principi M; Francavilla R; Pisani A; Rendina M; Panella C; Francavilla A
    Transplant Proc; 2001 May; 33(3):2107-9. PubMed ID: 11377467
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease.
    Casson DH; Eltumi M; Tomlin S; Walker-Smith JA; Murch SH
    Gut; 2000 Sep; 47(3):436-40. PubMed ID: 10940284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus toxicity following topical treatment of perianal Crohn's disease: an admonitory anecdote.
    Ali FR; Lyon CC
    J Crohns Colitis; 2013 Dec; 7(12):e713. PubMed ID: 24076430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lamprene in ano-perineal lesions of Crohn's disease. A retrospective study].
    Pinès AE; Cosnes J; Carbonnel F; Ngo Y; Beaugerie L; Gendre JP; Le Quintrec Y
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):155-63. PubMed ID: 8239487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of metastatic Crohn's disease with cyclosporine.
    Carranza DC; Young L
    J Drugs Dermatol; 2008 Aug; 7(8):789-91. PubMed ID: 18720698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.
    Ierardi E; Principi M; Francavilla R; Pisani A; Rendina M; Ingrosso M; Guglielmi FW; Panella C; Francavilla A
    Aliment Pharmacol Ther; 2001 Mar; 15(3):371-7. PubMed ID: 11207512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus and Crohn disease.
    Hodgson T; Hegarty A; Porter S
    J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):633. PubMed ID: 11740245
    [No Abstract]   [Full Text] [Related]  

  • 17. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
    Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
    Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
    Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Razoxane for Crohn's colitis and non-specific proctitis.
    Kingston RD; Hellman K
    Br J Clin Pract; 1992; 46(4):252-5. PubMed ID: 1290734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.